Global Subcutaneous Drug Delivery Equipment Supply, Demand and Key Producers, 2026-2032
The global Subcutaneous Drug Delivery Equipment market size is expected to reach $ 60014 million by 2032, rising at a market growth of 8.0% CAGR during the forecast period (2026-2032).
Subcutaneous Drug Delivery Equipment refers to a class of drug delivery devices or systems that administer drugs into the subcutaneous tissue, with the core value of bypassing the skin's stratum corneum barrier to achieve efficient drug absorption. From an industry perspective, this field encompasses three major technological forms. The first is traditional needle-based devices such as auto-injectors and prefilled syringes. The second is on-body injectors, which are wearable devices that adhere to the skin and can be programmed to automatically complete subcutaneous delivery of large-volume or high-viscosity drugs. The third is implantable devices such as subcutaneous implants and implantable infusion ports. The subcutaneous tissue lies beneath the dermis and consists of loose connective tissue and adipose tissue, rich in capillaries and lymphatic vessels, allowing drugs to rapidly enter systemic circulation after injection while exhibiting low local proteolytic enzyme activity, making it particularly suitable for the delivery of large-molecule drugs. In recent years, with the explosive growth of biologics, subcutaneous drug delivery has transitioned from a complementary approach to intravenous infusion into the core infrastructure for biologic commercialization. This shift not only compresses the single administration time from tens of minutes for intravenous infusion to minutes, but also drives the migration of treatment settings from hospitals to homes, enabling patients or their caregivers to perform administration, thereby reshaping the competitive landscape of the global pharmaceutical industry.
Market Development Opportunities and Key Drivers
The mature application of recombinant human hyaluronidase has enabled single subcutaneous injection volume to surpass the traditional 1.5 mL limit, removing barriers for subcutaneous administration of biologics such as monoclonal antibodies and peptides. The rising global prevalence of chronic diseases is driving rigid demand for home-use drug delivery devices. In 2024, the U.S. Food and Drug Administration consecutively approved multiple subcutaneous tumor immunotherapy products, while China's National Medical Products Administration included subcutaneous drug delivery formulations in the expansion categories for generic drug consistency evaluation. Large pharmaceutical companies are treating subcutaneous drug delivery platforms as strategic assets to extend core product lifecycles through acquisitions and collaborations.
Market Challenges and Risks
As drug-device combination products, subcutaneous drug delivery equipment must satisfy dual regulatory review requirements for both pharmaceuticals and devices, and divergent interpretations of the primary mode of action across jurisdictions often lead to extended review cycles. The European Medical Device Regulation has elevated auto-injectors to Class III status while notified body certification capacity remains constrained. Wearable injectors carry high costs, making widespread adoption difficult in self-pay dominant markets, and U.S. payers commonly require prior authorization for biologics with high annual costs. Critical components remain concentrated among a limited number of suppliers, making supply chain geopolitical risks a concern.
Downstream Demand Trends
Large pharmaceutical companies are treating subcutaneous drug delivery platforms as strategic assets to counter biosimilar competition through acquisitions and licensing. In 2025, Enable Injections' enFuse system received regulatory approvals from both Brazil and the United Kingdom, signaling that wearable large-volume subcutaneous injection technology is gaining global regulatory acceptance. Chronic disease patients favor wearable injectors that can be worn for hours to automatically complete drug delivery, while oncology patients value the reduction of treatment time from half a day to minutes. The United Kingdom government has initiated a multi-billion pound program to promote hybrid closed-loop insulin systems, reflecting public payers' confidence in home-based subcutaneous drug delivery models.
Regional Trends
North America continues to dominate innovation and early commercialization, leveraging its dense biopharmaceutical clusters and mature drug-device combination review experience, with the U.S. Food and Drug Administration approving multiple subcutaneous tumor immunotherapy products in 2024. Europe emphasizes real-world evidence and health technology assessment, with Germany's Federal Joint Committee imposing stricter requirements for additional benefit assessment of novel drug-device combination products, positioning the region as a critical proving ground for clinical and economic value. China and the broader Asia-Pacific region are transitioning from generic following to integrated innovation, with large chronic disease patient populations and rapidly iterating manufacturing capabilities providing unique engineering advantages for local companies.
This report studies the global Subcutaneous Drug Delivery Equipment production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Subcutaneous Drug Delivery Equipment and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Subcutaneous Drug Delivery Equipment that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Subcutaneous Drug Delivery Equipment total production and demand, 2021-2032, (Units)
Global Subcutaneous Drug Delivery Equipment total production value, 2021-2032, (USD Million)
Global Subcutaneous Drug Delivery Equipment production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Units), (based on production site)
Global Subcutaneous Drug Delivery Equipment consumption by region & country, CAGR, 2021-2032 & (Units)
U.S. VS China: Subcutaneous Drug Delivery Equipment domestic production, consumption, key domestic manufacturers and share
Global Subcutaneous Drug Delivery Equipment production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Units)
Global Subcutaneous Drug Delivery Equipment production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Units)
Global Subcutaneous Drug Delivery Equipment production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Units)
This report profiles key players in the global Subcutaneous Drug Delivery Equipment market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Becton Dickinson, Ypsomed, SHL Medical, West Pharmaceutical Services, Gerresheimer, Owen Mumford, Novo Nordisk, Nemera, Tandem Diabetes Care, Enable Injections, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Subcutaneous Drug Delivery Equipment market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Units) and average price (USD/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Subcutaneous Drug Delivery Equipment Market, By Region:
1. How big is the global Subcutaneous Drug Delivery Equipment market?
2. What is the demand of the global Subcutaneous Drug Delivery Equipment market?
3. What is the year over year growth of the global Subcutaneous Drug Delivery Equipment market?
4. What is the production and production value of the global Subcutaneous Drug Delivery Equipment market?
5. Who are the key producers in the global Subcutaneous Drug Delivery Equipment market?
6. What are the growth factors driving the market demand?
Subcutaneous Drug Delivery Equipment refers to a class of drug delivery devices or systems that administer drugs into the subcutaneous tissue, with the core value of bypassing the skin's stratum corneum barrier to achieve efficient drug absorption. From an industry perspective, this field encompasses three major technological forms. The first is traditional needle-based devices such as auto-injectors and prefilled syringes. The second is on-body injectors, which are wearable devices that adhere to the skin and can be programmed to automatically complete subcutaneous delivery of large-volume or high-viscosity drugs. The third is implantable devices such as subcutaneous implants and implantable infusion ports. The subcutaneous tissue lies beneath the dermis and consists of loose connective tissue and adipose tissue, rich in capillaries and lymphatic vessels, allowing drugs to rapidly enter systemic circulation after injection while exhibiting low local proteolytic enzyme activity, making it particularly suitable for the delivery of large-molecule drugs. In recent years, with the explosive growth of biologics, subcutaneous drug delivery has transitioned from a complementary approach to intravenous infusion into the core infrastructure for biologic commercialization. This shift not only compresses the single administration time from tens of minutes for intravenous infusion to minutes, but also drives the migration of treatment settings from hospitals to homes, enabling patients or their caregivers to perform administration, thereby reshaping the competitive landscape of the global pharmaceutical industry.
Market Development Opportunities and Key Drivers
The mature application of recombinant human hyaluronidase has enabled single subcutaneous injection volume to surpass the traditional 1.5 mL limit, removing barriers for subcutaneous administration of biologics such as monoclonal antibodies and peptides. The rising global prevalence of chronic diseases is driving rigid demand for home-use drug delivery devices. In 2024, the U.S. Food and Drug Administration consecutively approved multiple subcutaneous tumor immunotherapy products, while China's National Medical Products Administration included subcutaneous drug delivery formulations in the expansion categories for generic drug consistency evaluation. Large pharmaceutical companies are treating subcutaneous drug delivery platforms as strategic assets to extend core product lifecycles through acquisitions and collaborations.
Market Challenges and Risks
As drug-device combination products, subcutaneous drug delivery equipment must satisfy dual regulatory review requirements for both pharmaceuticals and devices, and divergent interpretations of the primary mode of action across jurisdictions often lead to extended review cycles. The European Medical Device Regulation has elevated auto-injectors to Class III status while notified body certification capacity remains constrained. Wearable injectors carry high costs, making widespread adoption difficult in self-pay dominant markets, and U.S. payers commonly require prior authorization for biologics with high annual costs. Critical components remain concentrated among a limited number of suppliers, making supply chain geopolitical risks a concern.
Downstream Demand Trends
Large pharmaceutical companies are treating subcutaneous drug delivery platforms as strategic assets to counter biosimilar competition through acquisitions and licensing. In 2025, Enable Injections' enFuse system received regulatory approvals from both Brazil and the United Kingdom, signaling that wearable large-volume subcutaneous injection technology is gaining global regulatory acceptance. Chronic disease patients favor wearable injectors that can be worn for hours to automatically complete drug delivery, while oncology patients value the reduction of treatment time from half a day to minutes. The United Kingdom government has initiated a multi-billion pound program to promote hybrid closed-loop insulin systems, reflecting public payers' confidence in home-based subcutaneous drug delivery models.
Regional Trends
North America continues to dominate innovation and early commercialization, leveraging its dense biopharmaceutical clusters and mature drug-device combination review experience, with the U.S. Food and Drug Administration approving multiple subcutaneous tumor immunotherapy products in 2024. Europe emphasizes real-world evidence and health technology assessment, with Germany's Federal Joint Committee imposing stricter requirements for additional benefit assessment of novel drug-device combination products, positioning the region as a critical proving ground for clinical and economic value. China and the broader Asia-Pacific region are transitioning from generic following to integrated innovation, with large chronic disease patient populations and rapidly iterating manufacturing capabilities providing unique engineering advantages for local companies.
This report studies the global Subcutaneous Drug Delivery Equipment production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Subcutaneous Drug Delivery Equipment and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Subcutaneous Drug Delivery Equipment that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Subcutaneous Drug Delivery Equipment total production and demand, 2021-2032, (Units)
Global Subcutaneous Drug Delivery Equipment total production value, 2021-2032, (USD Million)
Global Subcutaneous Drug Delivery Equipment production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Units), (based on production site)
Global Subcutaneous Drug Delivery Equipment consumption by region & country, CAGR, 2021-2032 & (Units)
U.S. VS China: Subcutaneous Drug Delivery Equipment domestic production, consumption, key domestic manufacturers and share
Global Subcutaneous Drug Delivery Equipment production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Units)
Global Subcutaneous Drug Delivery Equipment production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Units)
Global Subcutaneous Drug Delivery Equipment production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Units)
This report profiles key players in the global Subcutaneous Drug Delivery Equipment market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Becton Dickinson, Ypsomed, SHL Medical, West Pharmaceutical Services, Gerresheimer, Owen Mumford, Novo Nordisk, Nemera, Tandem Diabetes Care, Enable Injections, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Subcutaneous Drug Delivery Equipment market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Units) and average price (USD/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Subcutaneous Drug Delivery Equipment Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Syringe
- Injection Pen
- Implantable Device
- Manual Injection Device
- Spring Driven Device
- Motor Driven Device
- Gas-Powered Device
- Small Molecule Device
- Peptide and Protein Device
- Nucleic Acid Device
- Disposable Device
- Reusable Device
- Disease Treatment
- Vaccination
- Aesthetics and Cosmetics
- Becton Dickinson
- Ypsomed
- SHL Medical
- West Pharmaceutical Services
- Gerresheimer
- Owen Mumford
- Novo Nordisk
- Nemera
- Tandem Diabetes Care
- Enable Injections
- Stevanato Group
- MicroPort
- Weigao Group
1. How big is the global Subcutaneous Drug Delivery Equipment market?
2. What is the demand of the global Subcutaneous Drug Delivery Equipment market?
3. What is the year over year growth of the global Subcutaneous Drug Delivery Equipment market?
4. What is the production and production value of the global Subcutaneous Drug Delivery Equipment market?
5. Who are the key producers in the global Subcutaneous Drug Delivery Equipment market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Subcutaneous Drug Delivery Equipment Introduction
1.2 World Subcutaneous Drug Delivery Equipment Supply & Forecast
1.2.1 World Subcutaneous Drug Delivery Equipment Production Value (2021 & 2025 & 2032)
1.2.2 World Subcutaneous Drug Delivery Equipment Production (2021-2032)
1.2.3 World Subcutaneous Drug Delivery Equipment Pricing Trends (2021-2032)
1.3 World Subcutaneous Drug Delivery Equipment Production by Region (Based on Production Site)
1.3.1 World Subcutaneous Drug Delivery Equipment Production Value by Region (2021-2032)
1.3.2 World Subcutaneous Drug Delivery Equipment Production by Region (2021-2032)
1.3.3 World Subcutaneous Drug Delivery Equipment Average Price by Region (2021-2032)
1.3.4 North America Subcutaneous Drug Delivery Equipment Production (2021-2032)
1.3.5 Europe Subcutaneous Drug Delivery Equipment Production (2021-2032)
1.3.6 Asia Subcutaneous Drug Delivery Equipment Production (2021-2032)
1.3.7 Latin America Subcutaneous Drug Delivery Equipment Production (2021-2032)
1.3.8 Middle East Subcutaneous Drug Delivery Equipment Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Subcutaneous Drug Delivery Equipment Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Subcutaneous Drug Delivery Equipment Major Market Trends
2 DEMAND SUMMARY
2.1 World Subcutaneous Drug Delivery Equipment Demand (2021-2032)
2.2 World Subcutaneous Drug Delivery Equipment Consumption by Region
2.2.1 World Subcutaneous Drug Delivery Equipment Consumption by Region (2021-2026)
2.2.2 World Subcutaneous Drug Delivery Equipment Consumption Forecast by Region (2027-2032)
2.3 United States Subcutaneous Drug Delivery Equipment Consumption (2021-2032)
2.4 China Subcutaneous Drug Delivery Equipment Consumption (2021-2032)
2.5 Europe Subcutaneous Drug Delivery Equipment Consumption (2021-2032)
2.6 Japan Subcutaneous Drug Delivery Equipment Consumption (2021-2032)
2.7 South Korea Subcutaneous Drug Delivery Equipment Consumption (2021-2032)
2.8 ASEAN Subcutaneous Drug Delivery Equipment Consumption (2021-2032)
2.9 India Subcutaneous Drug Delivery Equipment Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Subcutaneous Drug Delivery Equipment Production Value by Manufacturer (2021-2026)
3.2 World Subcutaneous Drug Delivery Equipment Production by Manufacturer (2021-2026)
3.3 World Subcutaneous Drug Delivery Equipment Average Price by Manufacturer (2021-2026)
3.4 Subcutaneous Drug Delivery Equipment Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Subcutaneous Drug Delivery Equipment Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Subcutaneous Drug Delivery Equipment in 2025
3.5.3 Global Concentration Ratios (CR8) for Subcutaneous Drug Delivery Equipment in 2025
3.6 Subcutaneous Drug Delivery Equipment Market: Overall Company Footprint Analysis
3.6.1 Subcutaneous Drug Delivery Equipment Market: Region Footprint
3.6.2 Subcutaneous Drug Delivery Equipment Market: Company Product Type Footprint
3.6.3 Subcutaneous Drug Delivery Equipment Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Subcutaneous Drug Delivery Equipment Production Value Comparison
4.1.1 United States VS China: Subcutaneous Drug Delivery Equipment Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Subcutaneous Drug Delivery Equipment Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Subcutaneous Drug Delivery Equipment Production Comparison
4.2.1 United States VS China: Subcutaneous Drug Delivery Equipment Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Subcutaneous Drug Delivery Equipment Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Subcutaneous Drug Delivery Equipment Consumption Comparison
4.3.1 United States VS China: Subcutaneous Drug Delivery Equipment Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Subcutaneous Drug Delivery Equipment Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Subcutaneous Drug Delivery Equipment Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Subcutaneous Drug Delivery Equipment Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Subcutaneous Drug Delivery Equipment Production Value (2021-2026)
4.4.3 United States Based Manufacturers Subcutaneous Drug Delivery Equipment Production (2021-2026)
4.5 China Based Subcutaneous Drug Delivery Equipment Manufacturers and Market Share
4.5.1 China Based Subcutaneous Drug Delivery Equipment Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Subcutaneous Drug Delivery Equipment Production Value (2021-2026)
4.5.3 China Based Manufacturers Subcutaneous Drug Delivery Equipment Production (2021-2026)
4.6 Rest of World Based Subcutaneous Drug Delivery Equipment Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Subcutaneous Drug Delivery Equipment Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Subcutaneous Drug Delivery Equipment Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Subcutaneous Drug Delivery Equipment Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Subcutaneous Drug Delivery Equipment Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Syringe
5.2.2 Injection Pen
5.2.3 Implantable Device
5.3 Market Segment by Type
5.3.1 World Subcutaneous Drug Delivery Equipment Production by Type (2021-2032)
5.3.2 World Subcutaneous Drug Delivery Equipment Production Value by Type (2021-2032)
5.3.3 World Subcutaneous Drug Delivery Equipment Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY DELIVERY MECHANISM
6.1 World Subcutaneous Drug Delivery Equipment Market Size Overview by Delivery Mechanism: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Delivery Mechanism
6.2.1 Manual Injection Device
6.2.2 Spring Driven Device
6.2.3 Motor Driven Device
6.2.4 Gas-Powered Device
6.3 Market Segment by Delivery Mechanism
6.3.1 World Subcutaneous Drug Delivery Equipment Production by Delivery Mechanism (2021-2032)
6.3.2 World Subcutaneous Drug Delivery Equipment Production Value by Delivery Mechanism (2021-2032)
6.3.3 World Subcutaneous Drug Delivery Equipment Average Price by Delivery Mechanism (2021-2032)
7 MARKET ANALYSIS BY DRUG TYPE
7.1 World Subcutaneous Drug Delivery Equipment Market Size Overview by Drug Type: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Drug Type
7.2.1 Small Molecule Device
7.2.2 Peptide and Protein Device
7.2.3 Nucleic Acid Device
7.3 Market Segment by Drug Type
7.3.1 World Subcutaneous Drug Delivery Equipment Production by Drug Type (2021-2032)
7.3.2 World Subcutaneous Drug Delivery Equipment Production Value by Drug Type (2021-2032)
7.3.3 World Subcutaneous Drug Delivery Equipment Average Price by Drug Type (2021-2032)
8 MARKET ANALYSIS BY REUSABILITY
8.1 World Subcutaneous Drug Delivery Equipment Market Size Overview by Reusability: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Reusability
8.2.1 Disposable Device
8.2.2 Reusable Device
8.3 Market Segment by Reusability
8.3.1 World Subcutaneous Drug Delivery Equipment Production by Reusability (2021-2032)
8.3.2 World Subcutaneous Drug Delivery Equipment Production Value by Reusability (2021-2032)
8.3.3 World Subcutaneous Drug Delivery Equipment Average Price by Reusability (2021-2032)
9 MARKET ANALYSIS BY APPLICATION
9.1 World Subcutaneous Drug Delivery Equipment Market Size Overview by Application: 2021 VS 2025 VS 2032
9.2 Segment Introduction by Application
9.2.1 Disease Treatment
9.2.2 Vaccination
9.2.3 Aesthetics and Cosmetics
9.3 Market Segment by Application
9.3.1 World Subcutaneous Drug Delivery Equipment Production by Application (2021-2032)
9.3.2 World Subcutaneous Drug Delivery Equipment Production Value by Application (2021-2032)
9.3.3 World Subcutaneous Drug Delivery Equipment Average Price by Application (2021-2032)
10 COMPANY PROFILES
10.1 Becton Dickinson
10.1.1 Becton Dickinson Details
10.1.2 Becton Dickinson Major Business
10.1.3 Becton Dickinson Subcutaneous Drug Delivery Equipment Product and Services
10.1.4 Becton Dickinson Subcutaneous Drug Delivery Equipment Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.1.5 Becton Dickinson Recent Developments/Updates
10.1.6 Becton Dickinson Competitive Strengths & Weaknesses
10.2 Ypsomed
10.2.1 Ypsomed Details
10.2.2 Ypsomed Major Business
10.2.3 Ypsomed Subcutaneous Drug Delivery Equipment Product and Services
10.2.4 Ypsomed Subcutaneous Drug Delivery Equipment Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.2.5 Ypsomed Recent Developments/Updates
10.2.6 Ypsomed Competitive Strengths & Weaknesses
10.3 SHL Medical
10.3.1 SHL Medical Details
10.3.2 SHL Medical Major Business
10.3.3 SHL Medical Subcutaneous Drug Delivery Equipment Product and Services
10.3.4 SHL Medical Subcutaneous Drug Delivery Equipment Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.3.5 SHL Medical Recent Developments/Updates
10.3.6 SHL Medical Competitive Strengths & Weaknesses
10.4 West Pharmaceutical Services
10.4.1 West Pharmaceutical Services Details
10.4.2 West Pharmaceutical Services Major Business
10.4.3 West Pharmaceutical Services Subcutaneous Drug Delivery Equipment Product and Services
10.4.4 West Pharmaceutical Services Subcutaneous Drug Delivery Equipment Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.4.5 West Pharmaceutical Services Recent Developments/Updates
10.4.6 West Pharmaceutical Services Competitive Strengths & Weaknesses
10.5 Gerresheimer
10.5.1 Gerresheimer Details
10.5.2 Gerresheimer Major Business
10.5.3 Gerresheimer Subcutaneous Drug Delivery Equipment Product and Services
10.5.4 Gerresheimer Subcutaneous Drug Delivery Equipment Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.5.5 Gerresheimer Recent Developments/Updates
10.5.6 Gerresheimer Competitive Strengths & Weaknesses
10.6 Owen Mumford
10.6.1 Owen Mumford Details
10.6.2 Owen Mumford Major Business
10.6.3 Owen Mumford Subcutaneous Drug Delivery Equipment Product and Services
10.6.4 Owen Mumford Subcutaneous Drug Delivery Equipment Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.6.5 Owen Mumford Recent Developments/Updates
10.6.6 Owen Mumford Competitive Strengths & Weaknesses
10.7 Novo Nordisk
10.7.1 Novo Nordisk Details
10.7.2 Novo Nordisk Major Business
10.7.3 Novo Nordisk Subcutaneous Drug Delivery Equipment Product and Services
10.7.4 Novo Nordisk Subcutaneous Drug Delivery Equipment Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.7.5 Novo Nordisk Recent Developments/Updates
10.7.6 Novo Nordisk Competitive Strengths & Weaknesses
10.8 Nemera
10.8.1 Nemera Details
10.8.2 Nemera Major Business
10.8.3 Nemera Subcutaneous Drug Delivery Equipment Product and Services
10.8.4 Nemera Subcutaneous Drug Delivery Equipment Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.8.5 Nemera Recent Developments/Updates
10.8.6 Nemera Competitive Strengths & Weaknesses
10.9 Tandem Diabetes Care
10.9.1 Tandem Diabetes Care Details
10.9.2 Tandem Diabetes Care Major Business
10.9.3 Tandem Diabetes Care Subcutaneous Drug Delivery Equipment Product and Services
10.9.4 Tandem Diabetes Care Subcutaneous Drug Delivery Equipment Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.9.5 Tandem Diabetes Care Recent Developments/Updates
10.9.6 Tandem Diabetes Care Competitive Strengths & Weaknesses
10.10 Enable Injections
10.10.1 Enable Injections Details
10.10.2 Enable Injections Major Business
10.10.3 Enable Injections Subcutaneous Drug Delivery Equipment Product and Services
10.10.4 Enable Injections Subcutaneous Drug Delivery Equipment Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.10.5 Enable Injections Recent Developments/Updates
10.10.6 Enable Injections Competitive Strengths & Weaknesses
10.11 Stevanato Group
10.11.1 Stevanato Group Details
10.11.2 Stevanato Group Major Business
10.11.3 Stevanato Group Subcutaneous Drug Delivery Equipment Product and Services
10.11.4 Stevanato Group Subcutaneous Drug Delivery Equipment Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.11.5 Stevanato Group Recent Developments/Updates
10.11.6 Stevanato Group Competitive Strengths & Weaknesses
10.12 MicroPort
10.12.1 MicroPort Details
10.12.2 MicroPort Major Business
10.12.3 MicroPort Subcutaneous Drug Delivery Equipment Product and Services
10.12.4 MicroPort Subcutaneous Drug Delivery Equipment Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.12.5 MicroPort Recent Developments/Updates
10.12.6 MicroPort Competitive Strengths & Weaknesses
10.13 Weigao Group
10.13.1 Weigao Group Details
10.13.2 Weigao Group Major Business
10.13.3 Weigao Group Subcutaneous Drug Delivery Equipment Product and Services
10.13.4 Weigao Group Subcutaneous Drug Delivery Equipment Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.13.5 Weigao Group Recent Developments/Updates
10.13.6 Weigao Group Competitive Strengths & Weaknesses
11 INDUSTRY CHAIN ANALYSIS
11.1 Subcutaneous Drug Delivery Equipment Industry Chain
11.2 Subcutaneous Drug Delivery Equipment Upstream Analysis
11.2.1 Subcutaneous Drug Delivery Equipment Core Raw Materials
11.2.2 Main Manufacturers of Subcutaneous Drug Delivery Equipment Core Raw Materials
11.3 Midstream Analysis
11.4 Downstream Analysis
11.5 Subcutaneous Drug Delivery Equipment Production Mode
11.6 Subcutaneous Drug Delivery Equipment Procurement Model
11.7 Subcutaneous Drug Delivery Equipment Industry Sales Model and Sales Channels
11.7.1 Subcutaneous Drug Delivery Equipment Sales Model
11.7.2 Subcutaneous Drug Delivery Equipment Typical Distributors
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Process and Data Source
13.3 Disclaimer
1.1 Subcutaneous Drug Delivery Equipment Introduction
1.2 World Subcutaneous Drug Delivery Equipment Supply & Forecast
1.2.1 World Subcutaneous Drug Delivery Equipment Production Value (2021 & 2025 & 2032)
1.2.2 World Subcutaneous Drug Delivery Equipment Production (2021-2032)
1.2.3 World Subcutaneous Drug Delivery Equipment Pricing Trends (2021-2032)
1.3 World Subcutaneous Drug Delivery Equipment Production by Region (Based on Production Site)
1.3.1 World Subcutaneous Drug Delivery Equipment Production Value by Region (2021-2032)
1.3.2 World Subcutaneous Drug Delivery Equipment Production by Region (2021-2032)
1.3.3 World Subcutaneous Drug Delivery Equipment Average Price by Region (2021-2032)
1.3.4 North America Subcutaneous Drug Delivery Equipment Production (2021-2032)
1.3.5 Europe Subcutaneous Drug Delivery Equipment Production (2021-2032)
1.3.6 Asia Subcutaneous Drug Delivery Equipment Production (2021-2032)
1.3.7 Latin America Subcutaneous Drug Delivery Equipment Production (2021-2032)
1.3.8 Middle East Subcutaneous Drug Delivery Equipment Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Subcutaneous Drug Delivery Equipment Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Subcutaneous Drug Delivery Equipment Major Market Trends
2 DEMAND SUMMARY
2.1 World Subcutaneous Drug Delivery Equipment Demand (2021-2032)
2.2 World Subcutaneous Drug Delivery Equipment Consumption by Region
2.2.1 World Subcutaneous Drug Delivery Equipment Consumption by Region (2021-2026)
2.2.2 World Subcutaneous Drug Delivery Equipment Consumption Forecast by Region (2027-2032)
2.3 United States Subcutaneous Drug Delivery Equipment Consumption (2021-2032)
2.4 China Subcutaneous Drug Delivery Equipment Consumption (2021-2032)
2.5 Europe Subcutaneous Drug Delivery Equipment Consumption (2021-2032)
2.6 Japan Subcutaneous Drug Delivery Equipment Consumption (2021-2032)
2.7 South Korea Subcutaneous Drug Delivery Equipment Consumption (2021-2032)
2.8 ASEAN Subcutaneous Drug Delivery Equipment Consumption (2021-2032)
2.9 India Subcutaneous Drug Delivery Equipment Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Subcutaneous Drug Delivery Equipment Production Value by Manufacturer (2021-2026)
3.2 World Subcutaneous Drug Delivery Equipment Production by Manufacturer (2021-2026)
3.3 World Subcutaneous Drug Delivery Equipment Average Price by Manufacturer (2021-2026)
3.4 Subcutaneous Drug Delivery Equipment Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Subcutaneous Drug Delivery Equipment Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Subcutaneous Drug Delivery Equipment in 2025
3.5.3 Global Concentration Ratios (CR8) for Subcutaneous Drug Delivery Equipment in 2025
3.6 Subcutaneous Drug Delivery Equipment Market: Overall Company Footprint Analysis
3.6.1 Subcutaneous Drug Delivery Equipment Market: Region Footprint
3.6.2 Subcutaneous Drug Delivery Equipment Market: Company Product Type Footprint
3.6.3 Subcutaneous Drug Delivery Equipment Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Subcutaneous Drug Delivery Equipment Production Value Comparison
4.1.1 United States VS China: Subcutaneous Drug Delivery Equipment Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Subcutaneous Drug Delivery Equipment Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Subcutaneous Drug Delivery Equipment Production Comparison
4.2.1 United States VS China: Subcutaneous Drug Delivery Equipment Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Subcutaneous Drug Delivery Equipment Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Subcutaneous Drug Delivery Equipment Consumption Comparison
4.3.1 United States VS China: Subcutaneous Drug Delivery Equipment Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Subcutaneous Drug Delivery Equipment Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Subcutaneous Drug Delivery Equipment Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Subcutaneous Drug Delivery Equipment Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Subcutaneous Drug Delivery Equipment Production Value (2021-2026)
4.4.3 United States Based Manufacturers Subcutaneous Drug Delivery Equipment Production (2021-2026)
4.5 China Based Subcutaneous Drug Delivery Equipment Manufacturers and Market Share
4.5.1 China Based Subcutaneous Drug Delivery Equipment Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Subcutaneous Drug Delivery Equipment Production Value (2021-2026)
4.5.3 China Based Manufacturers Subcutaneous Drug Delivery Equipment Production (2021-2026)
4.6 Rest of World Based Subcutaneous Drug Delivery Equipment Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Subcutaneous Drug Delivery Equipment Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Subcutaneous Drug Delivery Equipment Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Subcutaneous Drug Delivery Equipment Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Subcutaneous Drug Delivery Equipment Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Syringe
5.2.2 Injection Pen
5.2.3 Implantable Device
5.3 Market Segment by Type
5.3.1 World Subcutaneous Drug Delivery Equipment Production by Type (2021-2032)
5.3.2 World Subcutaneous Drug Delivery Equipment Production Value by Type (2021-2032)
5.3.3 World Subcutaneous Drug Delivery Equipment Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY DELIVERY MECHANISM
6.1 World Subcutaneous Drug Delivery Equipment Market Size Overview by Delivery Mechanism: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Delivery Mechanism
6.2.1 Manual Injection Device
6.2.2 Spring Driven Device
6.2.3 Motor Driven Device
6.2.4 Gas-Powered Device
6.3 Market Segment by Delivery Mechanism
6.3.1 World Subcutaneous Drug Delivery Equipment Production by Delivery Mechanism (2021-2032)
6.3.2 World Subcutaneous Drug Delivery Equipment Production Value by Delivery Mechanism (2021-2032)
6.3.3 World Subcutaneous Drug Delivery Equipment Average Price by Delivery Mechanism (2021-2032)
7 MARKET ANALYSIS BY DRUG TYPE
7.1 World Subcutaneous Drug Delivery Equipment Market Size Overview by Drug Type: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Drug Type
7.2.1 Small Molecule Device
7.2.2 Peptide and Protein Device
7.2.3 Nucleic Acid Device
7.3 Market Segment by Drug Type
7.3.1 World Subcutaneous Drug Delivery Equipment Production by Drug Type (2021-2032)
7.3.2 World Subcutaneous Drug Delivery Equipment Production Value by Drug Type (2021-2032)
7.3.3 World Subcutaneous Drug Delivery Equipment Average Price by Drug Type (2021-2032)
8 MARKET ANALYSIS BY REUSABILITY
8.1 World Subcutaneous Drug Delivery Equipment Market Size Overview by Reusability: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Reusability
8.2.1 Disposable Device
8.2.2 Reusable Device
8.3 Market Segment by Reusability
8.3.1 World Subcutaneous Drug Delivery Equipment Production by Reusability (2021-2032)
8.3.2 World Subcutaneous Drug Delivery Equipment Production Value by Reusability (2021-2032)
8.3.3 World Subcutaneous Drug Delivery Equipment Average Price by Reusability (2021-2032)
9 MARKET ANALYSIS BY APPLICATION
9.1 World Subcutaneous Drug Delivery Equipment Market Size Overview by Application: 2021 VS 2025 VS 2032
9.2 Segment Introduction by Application
9.2.1 Disease Treatment
9.2.2 Vaccination
9.2.3 Aesthetics and Cosmetics
9.3 Market Segment by Application
9.3.1 World Subcutaneous Drug Delivery Equipment Production by Application (2021-2032)
9.3.2 World Subcutaneous Drug Delivery Equipment Production Value by Application (2021-2032)
9.3.3 World Subcutaneous Drug Delivery Equipment Average Price by Application (2021-2032)
10 COMPANY PROFILES
10.1 Becton Dickinson
10.1.1 Becton Dickinson Details
10.1.2 Becton Dickinson Major Business
10.1.3 Becton Dickinson Subcutaneous Drug Delivery Equipment Product and Services
10.1.4 Becton Dickinson Subcutaneous Drug Delivery Equipment Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.1.5 Becton Dickinson Recent Developments/Updates
10.1.6 Becton Dickinson Competitive Strengths & Weaknesses
10.2 Ypsomed
10.2.1 Ypsomed Details
10.2.2 Ypsomed Major Business
10.2.3 Ypsomed Subcutaneous Drug Delivery Equipment Product and Services
10.2.4 Ypsomed Subcutaneous Drug Delivery Equipment Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.2.5 Ypsomed Recent Developments/Updates
10.2.6 Ypsomed Competitive Strengths & Weaknesses
10.3 SHL Medical
10.3.1 SHL Medical Details
10.3.2 SHL Medical Major Business
10.3.3 SHL Medical Subcutaneous Drug Delivery Equipment Product and Services
10.3.4 SHL Medical Subcutaneous Drug Delivery Equipment Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.3.5 SHL Medical Recent Developments/Updates
10.3.6 SHL Medical Competitive Strengths & Weaknesses
10.4 West Pharmaceutical Services
10.4.1 West Pharmaceutical Services Details
10.4.2 West Pharmaceutical Services Major Business
10.4.3 West Pharmaceutical Services Subcutaneous Drug Delivery Equipment Product and Services
10.4.4 West Pharmaceutical Services Subcutaneous Drug Delivery Equipment Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.4.5 West Pharmaceutical Services Recent Developments/Updates
10.4.6 West Pharmaceutical Services Competitive Strengths & Weaknesses
10.5 Gerresheimer
10.5.1 Gerresheimer Details
10.5.2 Gerresheimer Major Business
10.5.3 Gerresheimer Subcutaneous Drug Delivery Equipment Product and Services
10.5.4 Gerresheimer Subcutaneous Drug Delivery Equipment Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.5.5 Gerresheimer Recent Developments/Updates
10.5.6 Gerresheimer Competitive Strengths & Weaknesses
10.6 Owen Mumford
10.6.1 Owen Mumford Details
10.6.2 Owen Mumford Major Business
10.6.3 Owen Mumford Subcutaneous Drug Delivery Equipment Product and Services
10.6.4 Owen Mumford Subcutaneous Drug Delivery Equipment Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.6.5 Owen Mumford Recent Developments/Updates
10.6.6 Owen Mumford Competitive Strengths & Weaknesses
10.7 Novo Nordisk
10.7.1 Novo Nordisk Details
10.7.2 Novo Nordisk Major Business
10.7.3 Novo Nordisk Subcutaneous Drug Delivery Equipment Product and Services
10.7.4 Novo Nordisk Subcutaneous Drug Delivery Equipment Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.7.5 Novo Nordisk Recent Developments/Updates
10.7.6 Novo Nordisk Competitive Strengths & Weaknesses
10.8 Nemera
10.8.1 Nemera Details
10.8.2 Nemera Major Business
10.8.3 Nemera Subcutaneous Drug Delivery Equipment Product and Services
10.8.4 Nemera Subcutaneous Drug Delivery Equipment Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.8.5 Nemera Recent Developments/Updates
10.8.6 Nemera Competitive Strengths & Weaknesses
10.9 Tandem Diabetes Care
10.9.1 Tandem Diabetes Care Details
10.9.2 Tandem Diabetes Care Major Business
10.9.3 Tandem Diabetes Care Subcutaneous Drug Delivery Equipment Product and Services
10.9.4 Tandem Diabetes Care Subcutaneous Drug Delivery Equipment Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.9.5 Tandem Diabetes Care Recent Developments/Updates
10.9.6 Tandem Diabetes Care Competitive Strengths & Weaknesses
10.10 Enable Injections
10.10.1 Enable Injections Details
10.10.2 Enable Injections Major Business
10.10.3 Enable Injections Subcutaneous Drug Delivery Equipment Product and Services
10.10.4 Enable Injections Subcutaneous Drug Delivery Equipment Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.10.5 Enable Injections Recent Developments/Updates
10.10.6 Enable Injections Competitive Strengths & Weaknesses
10.11 Stevanato Group
10.11.1 Stevanato Group Details
10.11.2 Stevanato Group Major Business
10.11.3 Stevanato Group Subcutaneous Drug Delivery Equipment Product and Services
10.11.4 Stevanato Group Subcutaneous Drug Delivery Equipment Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.11.5 Stevanato Group Recent Developments/Updates
10.11.6 Stevanato Group Competitive Strengths & Weaknesses
10.12 MicroPort
10.12.1 MicroPort Details
10.12.2 MicroPort Major Business
10.12.3 MicroPort Subcutaneous Drug Delivery Equipment Product and Services
10.12.4 MicroPort Subcutaneous Drug Delivery Equipment Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.12.5 MicroPort Recent Developments/Updates
10.12.6 MicroPort Competitive Strengths & Weaknesses
10.13 Weigao Group
10.13.1 Weigao Group Details
10.13.2 Weigao Group Major Business
10.13.3 Weigao Group Subcutaneous Drug Delivery Equipment Product and Services
10.13.4 Weigao Group Subcutaneous Drug Delivery Equipment Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.13.5 Weigao Group Recent Developments/Updates
10.13.6 Weigao Group Competitive Strengths & Weaknesses
11 INDUSTRY CHAIN ANALYSIS
11.1 Subcutaneous Drug Delivery Equipment Industry Chain
11.2 Subcutaneous Drug Delivery Equipment Upstream Analysis
11.2.1 Subcutaneous Drug Delivery Equipment Core Raw Materials
11.2.2 Main Manufacturers of Subcutaneous Drug Delivery Equipment Core Raw Materials
11.3 Midstream Analysis
11.4 Downstream Analysis
11.5 Subcutaneous Drug Delivery Equipment Production Mode
11.6 Subcutaneous Drug Delivery Equipment Procurement Model
11.7 Subcutaneous Drug Delivery Equipment Industry Sales Model and Sales Channels
11.7.1 Subcutaneous Drug Delivery Equipment Sales Model
11.7.2 Subcutaneous Drug Delivery Equipment Typical Distributors
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Process and Data Source
13.3 Disclaimer
LIST OF TABLES
Table 1. World Subcutaneous Drug Delivery Equipment Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Subcutaneous Drug Delivery Equipment Production Value by Region (2021-2026) & (USD Million)
Table 3. World Subcutaneous Drug Delivery Equipment Production Value by Region (2027-2032) & (USD Million)
Table 4. World Subcutaneous Drug Delivery Equipment Production Value Market Share by Region (2021-2026)
Table 5. World Subcutaneous Drug Delivery Equipment Production Value Market Share by Region (2027-2032)
Table 6. World Subcutaneous Drug Delivery Equipment Production by Region (2021-2026) & (Units)
Table 7. World Subcutaneous Drug Delivery Equipment Production by Region (2027-2032) & (Units)
Table 8. World Subcutaneous Drug Delivery Equipment Production Market Share by Region (2021-2026)
Table 9. World Subcutaneous Drug Delivery Equipment Production Market Share by Region (2027-2032)
Table 10. World Subcutaneous Drug Delivery Equipment Average Price by Region (2021-2026) & (USD/Unit)
Table 11. World Subcutaneous Drug Delivery Equipment Average Price by Region (2027-2032) & (USD/Unit)
Table 12. Subcutaneous Drug Delivery Equipment Major Market Trends
Table 13. World Subcutaneous Drug Delivery Equipment Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (Units)
Table 14. World Subcutaneous Drug Delivery Equipment Consumption by Region (2021-2026) & (Units)
Table 15. World Subcutaneous Drug Delivery Equipment Consumption Forecast by Region (2027-2032) & (Units)
Table 16. World Subcutaneous Drug Delivery Equipment Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Subcutaneous Drug Delivery Equipment Producers in 2025
Table 18. World Subcutaneous Drug Delivery Equipment Production by Manufacturer (2021-2026) & (Units)
Table 19. Production Market Share of Key Subcutaneous Drug Delivery Equipment Producers in 2025
Table 20. World Subcutaneous Drug Delivery Equipment Average Price by Manufacturer (2021-2026) & (USD/Unit)
Table 21. Global Subcutaneous Drug Delivery Equipment Company Evaluation Quadrant
Table 22. World Subcutaneous Drug Delivery Equipment Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Subcutaneous Drug Delivery Equipment Production Site of Key Manufacturer
Table 24. Subcutaneous Drug Delivery Equipment Market: Company Product Type Footprint
Table 25. Subcutaneous Drug Delivery Equipment Market: Company Product Application Footprint
Table 26. Subcutaneous Drug Delivery Equipment Competitive Factors
Table 27. Subcutaneous Drug Delivery Equipment New Entrant and Capacity Expansion Plans
Table 28. Subcutaneous Drug Delivery Equipment Mergers & Acquisitions Activity
Table 29. United States VS China Subcutaneous Drug Delivery Equipment Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Subcutaneous Drug Delivery Equipment Production Comparison, (2021 & 2025 & 2032) & (Units)
Table 31. United States VS China Subcutaneous Drug Delivery Equipment Consumption Comparison, (2021 & 2025 & 2032) & (Units)
Table 32. United States Based Subcutaneous Drug Delivery Equipment Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Subcutaneous Drug Delivery Equipment Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Subcutaneous Drug Delivery Equipment Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Subcutaneous Drug Delivery Equipment Production (2021-2026) & (Units)
Table 36. United States Based Manufacturers Subcutaneous Drug Delivery Equipment Production Market Share (2021-2026)
Table 37. China Based Subcutaneous Drug Delivery Equipment Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Subcutaneous Drug Delivery Equipment Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Subcutaneous Drug Delivery Equipment Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Subcutaneous Drug Delivery Equipment Production, (2021-2026) & (Units)
Table 41. China Based Manufacturers Subcutaneous Drug Delivery Equipment Production Market Share (2021-2026)
Table 42. Rest of World Based Subcutaneous Drug Delivery Equipment Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Subcutaneous Drug Delivery Equipment Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Subcutaneous Drug Delivery Equipment Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Subcutaneous Drug Delivery Equipment Production, (2021-2026) & (Units)
Table 46. Rest of World Based Manufacturers Subcutaneous Drug Delivery Equipment Production Market Share (2021-2026)
Table 47. World Subcutaneous Drug Delivery Equipment Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Subcutaneous Drug Delivery Equipment Production by Type (2021-2026) & (Units)
Table 49. World Subcutaneous Drug Delivery Equipment Production by Type (2027-2032) & (Units)
Table 50. World Subcutaneous Drug Delivery Equipment Production Value by Type (2021-2026) & (USD Million)
Table 51. World Subcutaneous Drug Delivery Equipment Production Value by Type (2027-2032) & (USD Million)
Table 52. World Subcutaneous Drug Delivery Equipment Average Price by Type (2021-2026) & (USD/Unit)
Table 53. World Subcutaneous Drug Delivery Equipment Average Price by Type (2027-2032) & (USD/Unit)
Table 54. World Subcutaneous Drug Delivery Equipment Production Value by Delivery Mechanism, (USD Million), 2021 & 2025 & 2032
Table 55. World Subcutaneous Drug Delivery Equipment Production by Delivery Mechanism (2021-2026) & (Units)
Table 56. World Subcutaneous Drug Delivery Equipment Production by Delivery Mechanism (2027-2032) & (Units)
Table 57. World Subcutaneous Drug Delivery Equipment Production Value by Delivery Mechanism (2021-2026) & (USD Million)
Table 58. World Subcutaneous Drug Delivery Equipment Production Value by Delivery Mechanism (2027-2032) & (USD Million)
Table 59. World Subcutaneous Drug Delivery Equipment Average Price by Delivery Mechanism (2021-2026) & (USD/Unit)
Table 60. World Subcutaneous Drug Delivery Equipment Average Price by Delivery Mechanism (2027-2032) & (USD/Unit)
Table 61. World Subcutaneous Drug Delivery Equipment Production Value by Drug Type, (USD Million), 2021 & 2025 & 2032
Table 62. World Subcutaneous Drug Delivery Equipment Production by Drug Type (2021-2026) & (Units)
Table 63. World Subcutaneous Drug Delivery Equipment Production by Drug Type (2027-2032) & (Units)
Table 64. World Subcutaneous Drug Delivery Equipment Production Value by Drug Type (2021-2026) & (USD Million)
Table 65. World Subcutaneous Drug Delivery Equipment Production Value by Drug Type (2027-2032) & (USD Million)
Table 66. World Subcutaneous Drug Delivery Equipment Average Price by Drug Type (2021-2026) & (USD/Unit)
Table 67. World Subcutaneous Drug Delivery Equipment Average Price by Drug Type (2027-2032) & (USD/Unit)
Table 68. World Subcutaneous Drug Delivery Equipment Production Value by Reusability, (USD Million), 2021 & 2025 & 2032
Table 69. World Subcutaneous Drug Delivery Equipment Production by Reusability (2021-2026) & (Units)
Table 70. World Subcutaneous Drug Delivery Equipment Production by Reusability (2027-2032) & (Units)
Table 71. World Subcutaneous Drug Delivery Equipment Production Value by Reusability (2021-2026) & (USD Million)
Table 72. World Subcutaneous Drug Delivery Equipment Production Value by Reusability (2027-2032) & (USD Million)
Table 73. World Subcutaneous Drug Delivery Equipment Average Price by Reusability (2021-2026) & (USD/Unit)
Table 74. World Subcutaneous Drug Delivery Equipment Average Price by Reusability (2027-2032) & (USD/Unit)
Table 75. World Subcutaneous Drug Delivery Equipment Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 76. World Subcutaneous Drug Delivery Equipment Production by Application (2021-2026) & (Units)
Table 77. World Subcutaneous Drug Delivery Equipment Production by Application (2027-2032) & (Units)
Table 78. World Subcutaneous Drug Delivery Equipment Production Value by Application (2021-2026) & (USD Million)
Table 79. World Subcutaneous Drug Delivery Equipment Production Value by Application (2027-2032) & (USD Million)
Table 80. World Subcutaneous Drug Delivery Equipment Average Price by Application (2021-2026) & (USD/Unit)
Table 81. World Subcutaneous Drug Delivery Equipment Average Price by Application (2027-2032) & (USD/Unit)
Table 82. Becton Dickinson Basic Information, Manufacturing Base and Competitors
Table 83. Becton Dickinson Major Business
Table 84. Becton Dickinson Subcutaneous Drug Delivery Equipment Product and Services
Table 85. Becton Dickinson Subcutaneous Drug Delivery Equipment Production (Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 86. Becton Dickinson Recent Developments/Updates
Table 87. Becton Dickinson Competitive Strengths & Weaknesses
Table 88. Ypsomed Basic Information, Manufacturing Base and Competitors
Table 89. Ypsomed Major Business
Table 90. Ypsomed Subcutaneous Drug Delivery Equipment Product and Services
Table 91. Ypsomed Subcutaneous Drug Delivery Equipment Production (Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 92. Ypsomed Recent Developments/Updates
Table 93. Ypsomed Competitive Strengths & Weaknesses
Table 94. SHL Medical Basic Information, Manufacturing Base and Competitors
Table 95. SHL Medical Major Business
Table 96. SHL Medical Subcutaneous Drug Delivery Equipment Product and Services
Table 97. SHL Medical Subcutaneous Drug Delivery Equipment Production (Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 98. SHL Medical Recent Developments/Updates
Table 99. SHL Medical Competitive Strengths & Weaknesses
Table 100. West Pharmaceutical Services Basic Information, Manufacturing Base and Competitors
Table 101. West Pharmaceutical Services Major Business
Table 102. West Pharmaceutical Services Subcutaneous Drug Delivery Equipment Product and Services
Table 103. West Pharmaceutical Services Subcutaneous Drug Delivery Equipment Production (Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 104. West Pharmaceutical Services Recent Developments/Updates
Table 105. West Pharmaceutical Services Competitive Strengths & Weaknesses
Table 106. Gerresheimer Basic Information, Manufacturing Base and Competitors
Table 107. Gerresheimer Major Business
Table 108. Gerresheimer Subcutaneous Drug Delivery Equipment Product and Services
Table 109. Gerresheimer Subcutaneous Drug Delivery Equipment Production (Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 110. Gerresheimer Recent Developments/Updates
Table 111. Gerresheimer Competitive Strengths & Weaknesses
Table 112. Owen Mumford Basic Information, Manufacturing Base and Competitors
Table 113. Owen Mumford Major Business
Table 114. Owen Mumford Subcutaneous Drug Delivery Equipment Product and Services
Table 115. Owen Mumford Subcutaneous Drug Delivery Equipment Production (Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 116. Owen Mumford Recent Developments/Updates
Table 117. Owen Mumford Competitive Strengths & Weaknesses
Table 118. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 119. Novo Nordisk Major Business
Table 120. Novo Nordisk Subcutaneous Drug Delivery Equipment Product and Services
Table 121. Novo Nordisk Subcutaneous Drug Delivery Equipment Production (Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 122. Novo Nordisk Recent Developments/Updates
Table 123. Novo Nordisk Competitive Strengths & Weaknesses
Table 124. Nemera Basic Information, Manufacturing Base and Competitors
Table 125. Nemera Major Business
Table 126. Nemera Subcutaneous Drug Delivery Equipment Product and Services
Table 127. Nemera Subcutaneous Drug Delivery Equipment Production (Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 128. Nemera Recent Developments/Updates
Table 129. Nemera Competitive Strengths & Weaknesses
Table 130. Tandem Diabetes Care Basic Information, Manufacturing Base and Competitors
Table 131. Tandem Diabetes Care Major Business
Table 132. Tandem Diabetes Care Subcutaneous Drug Delivery Equipment Product and Services
Table 133. Tandem Diabetes Care Subcutaneous Drug Delivery Equipment Production (Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 134. Tandem Diabetes Care Recent Developments/Updates
Table 135. Tandem Diabetes Care Competitive Strengths & Weaknesses
Table 136. Enable Injections Basic Information, Manufacturing Base and Competitors
Table 137. Enable Injections Major Business
Table 138. Enable Injections Subcutaneous Drug Delivery Equipment Product and Services
Table 139. Enable Injections Subcutaneous Drug Delivery Equipment Production (Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 140. Enable Injections Recent Developments/Updates
Table 141. Enable Injections Competitive Strengths & Weaknesses
Table 142. Stevanato Group Basic Information, Manufacturing Base and Competitors
Table 143. Stevanato Group Major Business
Table 144. Stevanato Group Subcutaneous Drug Delivery Equipment Product and Services
Table 145. Stevanato Group Subcutaneous Drug Delivery Equipment Production (Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 146. Stevanato Group Recent Developments/Updates
Table 147. Stevanato Group Competitive Strengths & Weaknesses
Table 148. MicroPort Basic Information, Manufacturing Base and Competitors
Table 149. MicroPort Major Business
Table 150. MicroPort Subcutaneous Drug Delivery Equipment Product and Services
Table 151. MicroPort Subcutaneous Drug Delivery Equipment Production (Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 152. MicroPort Recent Developments/Updates
Table 153. MicroPort Competitive Strengths & Weaknesses
Table 154. Weigao Group Basic Information, Manufacturing Base and Competitors
Table 155. Weigao Group Major Business
Table 156. Weigao Group Subcutaneous Drug Delivery Equipment Product and Services
Table 157. Weigao Group Subcutaneous Drug Delivery Equipment Production (Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 158. Weigao Group Recent Developments/Updates
Table 159. Weigao Group Competitive Strengths & Weaknesses
Table 160. Global Key Players of Subcutaneous Drug Delivery Equipment Upstream (Raw Materials)
Table 161. Global Subcutaneous Drug Delivery Equipment Typical Customers
Table 162. Subcutaneous Drug Delivery Equipment Typical Distributors
Table 1. World Subcutaneous Drug Delivery Equipment Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Subcutaneous Drug Delivery Equipment Production Value by Region (2021-2026) & (USD Million)
Table 3. World Subcutaneous Drug Delivery Equipment Production Value by Region (2027-2032) & (USD Million)
Table 4. World Subcutaneous Drug Delivery Equipment Production Value Market Share by Region (2021-2026)
Table 5. World Subcutaneous Drug Delivery Equipment Production Value Market Share by Region (2027-2032)
Table 6. World Subcutaneous Drug Delivery Equipment Production by Region (2021-2026) & (Units)
Table 7. World Subcutaneous Drug Delivery Equipment Production by Region (2027-2032) & (Units)
Table 8. World Subcutaneous Drug Delivery Equipment Production Market Share by Region (2021-2026)
Table 9. World Subcutaneous Drug Delivery Equipment Production Market Share by Region (2027-2032)
Table 10. World Subcutaneous Drug Delivery Equipment Average Price by Region (2021-2026) & (USD/Unit)
Table 11. World Subcutaneous Drug Delivery Equipment Average Price by Region (2027-2032) & (USD/Unit)
Table 12. Subcutaneous Drug Delivery Equipment Major Market Trends
Table 13. World Subcutaneous Drug Delivery Equipment Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (Units)
Table 14. World Subcutaneous Drug Delivery Equipment Consumption by Region (2021-2026) & (Units)
Table 15. World Subcutaneous Drug Delivery Equipment Consumption Forecast by Region (2027-2032) & (Units)
Table 16. World Subcutaneous Drug Delivery Equipment Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Subcutaneous Drug Delivery Equipment Producers in 2025
Table 18. World Subcutaneous Drug Delivery Equipment Production by Manufacturer (2021-2026) & (Units)
Table 19. Production Market Share of Key Subcutaneous Drug Delivery Equipment Producers in 2025
Table 20. World Subcutaneous Drug Delivery Equipment Average Price by Manufacturer (2021-2026) & (USD/Unit)
Table 21. Global Subcutaneous Drug Delivery Equipment Company Evaluation Quadrant
Table 22. World Subcutaneous Drug Delivery Equipment Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Subcutaneous Drug Delivery Equipment Production Site of Key Manufacturer
Table 24. Subcutaneous Drug Delivery Equipment Market: Company Product Type Footprint
Table 25. Subcutaneous Drug Delivery Equipment Market: Company Product Application Footprint
Table 26. Subcutaneous Drug Delivery Equipment Competitive Factors
Table 27. Subcutaneous Drug Delivery Equipment New Entrant and Capacity Expansion Plans
Table 28. Subcutaneous Drug Delivery Equipment Mergers & Acquisitions Activity
Table 29. United States VS China Subcutaneous Drug Delivery Equipment Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Subcutaneous Drug Delivery Equipment Production Comparison, (2021 & 2025 & 2032) & (Units)
Table 31. United States VS China Subcutaneous Drug Delivery Equipment Consumption Comparison, (2021 & 2025 & 2032) & (Units)
Table 32. United States Based Subcutaneous Drug Delivery Equipment Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Subcutaneous Drug Delivery Equipment Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Subcutaneous Drug Delivery Equipment Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Subcutaneous Drug Delivery Equipment Production (2021-2026) & (Units)
Table 36. United States Based Manufacturers Subcutaneous Drug Delivery Equipment Production Market Share (2021-2026)
Table 37. China Based Subcutaneous Drug Delivery Equipment Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Subcutaneous Drug Delivery Equipment Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Subcutaneous Drug Delivery Equipment Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Subcutaneous Drug Delivery Equipment Production, (2021-2026) & (Units)
Table 41. China Based Manufacturers Subcutaneous Drug Delivery Equipment Production Market Share (2021-2026)
Table 42. Rest of World Based Subcutaneous Drug Delivery Equipment Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Subcutaneous Drug Delivery Equipment Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Subcutaneous Drug Delivery Equipment Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Subcutaneous Drug Delivery Equipment Production, (2021-2026) & (Units)
Table 46. Rest of World Based Manufacturers Subcutaneous Drug Delivery Equipment Production Market Share (2021-2026)
Table 47. World Subcutaneous Drug Delivery Equipment Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Subcutaneous Drug Delivery Equipment Production by Type (2021-2026) & (Units)
Table 49. World Subcutaneous Drug Delivery Equipment Production by Type (2027-2032) & (Units)
Table 50. World Subcutaneous Drug Delivery Equipment Production Value by Type (2021-2026) & (USD Million)
Table 51. World Subcutaneous Drug Delivery Equipment Production Value by Type (2027-2032) & (USD Million)
Table 52. World Subcutaneous Drug Delivery Equipment Average Price by Type (2021-2026) & (USD/Unit)
Table 53. World Subcutaneous Drug Delivery Equipment Average Price by Type (2027-2032) & (USD/Unit)
Table 54. World Subcutaneous Drug Delivery Equipment Production Value by Delivery Mechanism, (USD Million), 2021 & 2025 & 2032
Table 55. World Subcutaneous Drug Delivery Equipment Production by Delivery Mechanism (2021-2026) & (Units)
Table 56. World Subcutaneous Drug Delivery Equipment Production by Delivery Mechanism (2027-2032) & (Units)
Table 57. World Subcutaneous Drug Delivery Equipment Production Value by Delivery Mechanism (2021-2026) & (USD Million)
Table 58. World Subcutaneous Drug Delivery Equipment Production Value by Delivery Mechanism (2027-2032) & (USD Million)
Table 59. World Subcutaneous Drug Delivery Equipment Average Price by Delivery Mechanism (2021-2026) & (USD/Unit)
Table 60. World Subcutaneous Drug Delivery Equipment Average Price by Delivery Mechanism (2027-2032) & (USD/Unit)
Table 61. World Subcutaneous Drug Delivery Equipment Production Value by Drug Type, (USD Million), 2021 & 2025 & 2032
Table 62. World Subcutaneous Drug Delivery Equipment Production by Drug Type (2021-2026) & (Units)
Table 63. World Subcutaneous Drug Delivery Equipment Production by Drug Type (2027-2032) & (Units)
Table 64. World Subcutaneous Drug Delivery Equipment Production Value by Drug Type (2021-2026) & (USD Million)
Table 65. World Subcutaneous Drug Delivery Equipment Production Value by Drug Type (2027-2032) & (USD Million)
Table 66. World Subcutaneous Drug Delivery Equipment Average Price by Drug Type (2021-2026) & (USD/Unit)
Table 67. World Subcutaneous Drug Delivery Equipment Average Price by Drug Type (2027-2032) & (USD/Unit)
Table 68. World Subcutaneous Drug Delivery Equipment Production Value by Reusability, (USD Million), 2021 & 2025 & 2032
Table 69. World Subcutaneous Drug Delivery Equipment Production by Reusability (2021-2026) & (Units)
Table 70. World Subcutaneous Drug Delivery Equipment Production by Reusability (2027-2032) & (Units)
Table 71. World Subcutaneous Drug Delivery Equipment Production Value by Reusability (2021-2026) & (USD Million)
Table 72. World Subcutaneous Drug Delivery Equipment Production Value by Reusability (2027-2032) & (USD Million)
Table 73. World Subcutaneous Drug Delivery Equipment Average Price by Reusability (2021-2026) & (USD/Unit)
Table 74. World Subcutaneous Drug Delivery Equipment Average Price by Reusability (2027-2032) & (USD/Unit)
Table 75. World Subcutaneous Drug Delivery Equipment Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 76. World Subcutaneous Drug Delivery Equipment Production by Application (2021-2026) & (Units)
Table 77. World Subcutaneous Drug Delivery Equipment Production by Application (2027-2032) & (Units)
Table 78. World Subcutaneous Drug Delivery Equipment Production Value by Application (2021-2026) & (USD Million)
Table 79. World Subcutaneous Drug Delivery Equipment Production Value by Application (2027-2032) & (USD Million)
Table 80. World Subcutaneous Drug Delivery Equipment Average Price by Application (2021-2026) & (USD/Unit)
Table 81. World Subcutaneous Drug Delivery Equipment Average Price by Application (2027-2032) & (USD/Unit)
Table 82. Becton Dickinson Basic Information, Manufacturing Base and Competitors
Table 83. Becton Dickinson Major Business
Table 84. Becton Dickinson Subcutaneous Drug Delivery Equipment Product and Services
Table 85. Becton Dickinson Subcutaneous Drug Delivery Equipment Production (Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 86. Becton Dickinson Recent Developments/Updates
Table 87. Becton Dickinson Competitive Strengths & Weaknesses
Table 88. Ypsomed Basic Information, Manufacturing Base and Competitors
Table 89. Ypsomed Major Business
Table 90. Ypsomed Subcutaneous Drug Delivery Equipment Product and Services
Table 91. Ypsomed Subcutaneous Drug Delivery Equipment Production (Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 92. Ypsomed Recent Developments/Updates
Table 93. Ypsomed Competitive Strengths & Weaknesses
Table 94. SHL Medical Basic Information, Manufacturing Base and Competitors
Table 95. SHL Medical Major Business
Table 96. SHL Medical Subcutaneous Drug Delivery Equipment Product and Services
Table 97. SHL Medical Subcutaneous Drug Delivery Equipment Production (Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 98. SHL Medical Recent Developments/Updates
Table 99. SHL Medical Competitive Strengths & Weaknesses
Table 100. West Pharmaceutical Services Basic Information, Manufacturing Base and Competitors
Table 101. West Pharmaceutical Services Major Business
Table 102. West Pharmaceutical Services Subcutaneous Drug Delivery Equipment Product and Services
Table 103. West Pharmaceutical Services Subcutaneous Drug Delivery Equipment Production (Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 104. West Pharmaceutical Services Recent Developments/Updates
Table 105. West Pharmaceutical Services Competitive Strengths & Weaknesses
Table 106. Gerresheimer Basic Information, Manufacturing Base and Competitors
Table 107. Gerresheimer Major Business
Table 108. Gerresheimer Subcutaneous Drug Delivery Equipment Product and Services
Table 109. Gerresheimer Subcutaneous Drug Delivery Equipment Production (Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 110. Gerresheimer Recent Developments/Updates
Table 111. Gerresheimer Competitive Strengths & Weaknesses
Table 112. Owen Mumford Basic Information, Manufacturing Base and Competitors
Table 113. Owen Mumford Major Business
Table 114. Owen Mumford Subcutaneous Drug Delivery Equipment Product and Services
Table 115. Owen Mumford Subcutaneous Drug Delivery Equipment Production (Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 116. Owen Mumford Recent Developments/Updates
Table 117. Owen Mumford Competitive Strengths & Weaknesses
Table 118. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 119. Novo Nordisk Major Business
Table 120. Novo Nordisk Subcutaneous Drug Delivery Equipment Product and Services
Table 121. Novo Nordisk Subcutaneous Drug Delivery Equipment Production (Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 122. Novo Nordisk Recent Developments/Updates
Table 123. Novo Nordisk Competitive Strengths & Weaknesses
Table 124. Nemera Basic Information, Manufacturing Base and Competitors
Table 125. Nemera Major Business
Table 126. Nemera Subcutaneous Drug Delivery Equipment Product and Services
Table 127. Nemera Subcutaneous Drug Delivery Equipment Production (Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 128. Nemera Recent Developments/Updates
Table 129. Nemera Competitive Strengths & Weaknesses
Table 130. Tandem Diabetes Care Basic Information, Manufacturing Base and Competitors
Table 131. Tandem Diabetes Care Major Business
Table 132. Tandem Diabetes Care Subcutaneous Drug Delivery Equipment Product and Services
Table 133. Tandem Diabetes Care Subcutaneous Drug Delivery Equipment Production (Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 134. Tandem Diabetes Care Recent Developments/Updates
Table 135. Tandem Diabetes Care Competitive Strengths & Weaknesses
Table 136. Enable Injections Basic Information, Manufacturing Base and Competitors
Table 137. Enable Injections Major Business
Table 138. Enable Injections Subcutaneous Drug Delivery Equipment Product and Services
Table 139. Enable Injections Subcutaneous Drug Delivery Equipment Production (Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 140. Enable Injections Recent Developments/Updates
Table 141. Enable Injections Competitive Strengths & Weaknesses
Table 142. Stevanato Group Basic Information, Manufacturing Base and Competitors
Table 143. Stevanato Group Major Business
Table 144. Stevanato Group Subcutaneous Drug Delivery Equipment Product and Services
Table 145. Stevanato Group Subcutaneous Drug Delivery Equipment Production (Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 146. Stevanato Group Recent Developments/Updates
Table 147. Stevanato Group Competitive Strengths & Weaknesses
Table 148. MicroPort Basic Information, Manufacturing Base and Competitors
Table 149. MicroPort Major Business
Table 150. MicroPort Subcutaneous Drug Delivery Equipment Product and Services
Table 151. MicroPort Subcutaneous Drug Delivery Equipment Production (Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 152. MicroPort Recent Developments/Updates
Table 153. MicroPort Competitive Strengths & Weaknesses
Table 154. Weigao Group Basic Information, Manufacturing Base and Competitors
Table 155. Weigao Group Major Business
Table 156. Weigao Group Subcutaneous Drug Delivery Equipment Product and Services
Table 157. Weigao Group Subcutaneous Drug Delivery Equipment Production (Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 158. Weigao Group Recent Developments/Updates
Table 159. Weigao Group Competitive Strengths & Weaknesses
Table 160. Global Key Players of Subcutaneous Drug Delivery Equipment Upstream (Raw Materials)
Table 161. Global Subcutaneous Drug Delivery Equipment Typical Customers
Table 162. Subcutaneous Drug Delivery Equipment Typical Distributors
LIST OF FIGURES
Figure 1. Subcutaneous Drug Delivery Equipment Picture
Figure 2. World Subcutaneous Drug Delivery Equipment Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Subcutaneous Drug Delivery Equipment Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Subcutaneous Drug Delivery Equipment Production (2021-2032) & (Units)
Figure 5. World Subcutaneous Drug Delivery Equipment Average Price (2021-2032) & (USD/Unit)
Figure 6. World Subcutaneous Drug Delivery Equipment Production Value Market Share by Region (2021-2032)
Figure 7. World Subcutaneous Drug Delivery Equipment Production Market Share by Region (2021-2032)
Figure 8. North America Subcutaneous Drug Delivery Equipment Production (2021-2032) & (Units)
Figure 9. Europe Subcutaneous Drug Delivery Equipment Production (2021-2032) & (Units)
Figure 10. Asia Subcutaneous Drug Delivery Equipment Production (2021-2032) & (Units)
Figure 11. Latin America Subcutaneous Drug Delivery Equipment Production (2021-2032) & (Units)
Figure 12. Middle East Subcutaneous Drug Delivery Equipment Production (2021-2032) & (Units)
Figure 13. Subcutaneous Drug Delivery Equipment Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Subcutaneous Drug Delivery Equipment Consumption (2021-2032) & (Units)
Figure 16. World Subcutaneous Drug Delivery Equipment Consumption Market Share by Region (2021-2032)
Figure 17. United States Subcutaneous Drug Delivery Equipment Consumption (2021-2032) & (Units)
Figure 18. China Subcutaneous Drug Delivery Equipment Consumption (2021-2032) & (Units)
Figure 19. Europe Subcutaneous Drug Delivery Equipment Consumption (2021-2032) & (Units)
Figure 20. Japan Subcutaneous Drug Delivery Equipment Consumption (2021-2032) & (Units)
Figure 21. South Korea Subcutaneous Drug Delivery Equipment Consumption (2021-2032) & (Units)
Figure 22. ASEAN Subcutaneous Drug Delivery Equipment Consumption (2021-2032) & (Units)
Figure 23. India Subcutaneous Drug Delivery Equipment Consumption (2021-2032) & (Units)
Figure 24. Producer Shipments of Subcutaneous Drug Delivery Equipment by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Subcutaneous Drug Delivery Equipment Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Subcutaneous Drug Delivery Equipment Markets in 2025
Figure 27. United States VS China: Subcutaneous Drug Delivery Equipment Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Subcutaneous Drug Delivery Equipment Production Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: Subcutaneous Drug Delivery Equipment Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States Based Manufacturers Subcutaneous Drug Delivery Equipment Production Market Share 2025
Figure 31. China Based Manufacturers Subcutaneous Drug Delivery Equipment Production Market Share 2025
Figure 32. Rest of World Based Manufacturers Subcutaneous Drug Delivery Equipment Production Market Share 2025
Figure 33. World Subcutaneous Drug Delivery Equipment Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 34. World Subcutaneous Drug Delivery Equipment Production Value Market Share by Type in 2025
Figure 35. Syringe
Figure 36. Injection Pen
Figure 37. Implantable Device
Figure 38. World Subcutaneous Drug Delivery Equipment Production Market Share by Type (2021-2032)
Figure 39. World Subcutaneous Drug Delivery Equipment Production Value Market Share by Type (2021-2032)
Figure 40. World Subcutaneous Drug Delivery Equipment Average Price by Type (2021-2032) & (USD/Unit)
Figure 41. World Subcutaneous Drug Delivery Equipment Production Value by Delivery Mechanism, (USD Million), 2021 & 2025 & 2032
Figure 42. World Subcutaneous Drug Delivery Equipment Production Value Market Share by Delivery Mechanism in 2025
Figure 43. Manual Injection Device
Figure 44. Spring Driven Device
Figure 45. Motor Driven Device
Figure 46. Gas-Powered Device
Figure 47. World Subcutaneous Drug Delivery Equipment Production Market Share by Delivery Mechanism (2021-2032)
Figure 48. World Subcutaneous Drug Delivery Equipment Production Value Market Share by Delivery Mechanism (2021-2032)
Figure 49. World Subcutaneous Drug Delivery Equipment Average Price by Delivery Mechanism (2021-2032) & (USD/Unit)
Figure 50. World Subcutaneous Drug Delivery Equipment Production Value by Drug Type, (USD Million), 2021 & 2025 & 2032
Figure 51. World Subcutaneous Drug Delivery Equipment Production Value Market Share by Drug Type in 2025
Figure 52. Small Molecule Device
Figure 53. Peptide and Protein Device
Figure 54. Nucleic Acid Device
Figure 55. World Subcutaneous Drug Delivery Equipment Production Market Share by Drug Type (2021-2032)
Figure 56. World Subcutaneous Drug Delivery Equipment Production Value Market Share by Drug Type (2021-2032)
Figure 57. World Subcutaneous Drug Delivery Equipment Average Price by Drug Type (2021-2032) & (USD/Unit)
Figure 58. World Subcutaneous Drug Delivery Equipment Production Value by Reusability, (USD Million), 2021 & 2025 & 2032
Figure 59. World Subcutaneous Drug Delivery Equipment Production Value Market Share by Reusability in 2025
Figure 60. Disposable Device
Figure 61. Reusable Device
Figure 62. World Subcutaneous Drug Delivery Equipment Production Market Share by Reusability (2021-2032)
Figure 63. World Subcutaneous Drug Delivery Equipment Production Value Market Share by Reusability (2021-2032)
Figure 64. World Subcutaneous Drug Delivery Equipment Average Price by Reusability (2021-2032) & (USD/Unit)
Figure 65. World Subcutaneous Drug Delivery Equipment Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 66. World Subcutaneous Drug Delivery Equipment Production Value Market Share by Application in 2025
Figure 67. Disease Treatment
Figure 68. Vaccination
Figure 69. Aesthetics and Cosmetics
Figure 70. World Subcutaneous Drug Delivery Equipment Production Market Share by Application (2021-2032)
Figure 71. World Subcutaneous Drug Delivery Equipment Production Value Market Share by Application (2021-2032)
Figure 72. World Subcutaneous Drug Delivery Equipment Average Price by Application (2021-2032) & (USD/Unit)
Figure 73. Subcutaneous Drug Delivery Equipment Industry Chain
Figure 74. Subcutaneous Drug Delivery Equipment Procurement Model
Figure 75. Subcutaneous Drug Delivery Equipment Sales Model
Figure 76. Subcutaneous Drug Delivery Equipment Sales Channels, Direct Sales, and Distribution
Figure 77. Methodology
Figure 78. Research Process and Data Source
Figure 1. Subcutaneous Drug Delivery Equipment Picture
Figure 2. World Subcutaneous Drug Delivery Equipment Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Subcutaneous Drug Delivery Equipment Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Subcutaneous Drug Delivery Equipment Production (2021-2032) & (Units)
Figure 5. World Subcutaneous Drug Delivery Equipment Average Price (2021-2032) & (USD/Unit)
Figure 6. World Subcutaneous Drug Delivery Equipment Production Value Market Share by Region (2021-2032)
Figure 7. World Subcutaneous Drug Delivery Equipment Production Market Share by Region (2021-2032)
Figure 8. North America Subcutaneous Drug Delivery Equipment Production (2021-2032) & (Units)
Figure 9. Europe Subcutaneous Drug Delivery Equipment Production (2021-2032) & (Units)
Figure 10. Asia Subcutaneous Drug Delivery Equipment Production (2021-2032) & (Units)
Figure 11. Latin America Subcutaneous Drug Delivery Equipment Production (2021-2032) & (Units)
Figure 12. Middle East Subcutaneous Drug Delivery Equipment Production (2021-2032) & (Units)
Figure 13. Subcutaneous Drug Delivery Equipment Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Subcutaneous Drug Delivery Equipment Consumption (2021-2032) & (Units)
Figure 16. World Subcutaneous Drug Delivery Equipment Consumption Market Share by Region (2021-2032)
Figure 17. United States Subcutaneous Drug Delivery Equipment Consumption (2021-2032) & (Units)
Figure 18. China Subcutaneous Drug Delivery Equipment Consumption (2021-2032) & (Units)
Figure 19. Europe Subcutaneous Drug Delivery Equipment Consumption (2021-2032) & (Units)
Figure 20. Japan Subcutaneous Drug Delivery Equipment Consumption (2021-2032) & (Units)
Figure 21. South Korea Subcutaneous Drug Delivery Equipment Consumption (2021-2032) & (Units)
Figure 22. ASEAN Subcutaneous Drug Delivery Equipment Consumption (2021-2032) & (Units)
Figure 23. India Subcutaneous Drug Delivery Equipment Consumption (2021-2032) & (Units)
Figure 24. Producer Shipments of Subcutaneous Drug Delivery Equipment by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Subcutaneous Drug Delivery Equipment Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Subcutaneous Drug Delivery Equipment Markets in 2025
Figure 27. United States VS China: Subcutaneous Drug Delivery Equipment Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Subcutaneous Drug Delivery Equipment Production Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: Subcutaneous Drug Delivery Equipment Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States Based Manufacturers Subcutaneous Drug Delivery Equipment Production Market Share 2025
Figure 31. China Based Manufacturers Subcutaneous Drug Delivery Equipment Production Market Share 2025
Figure 32. Rest of World Based Manufacturers Subcutaneous Drug Delivery Equipment Production Market Share 2025
Figure 33. World Subcutaneous Drug Delivery Equipment Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 34. World Subcutaneous Drug Delivery Equipment Production Value Market Share by Type in 2025
Figure 35. Syringe
Figure 36. Injection Pen
Figure 37. Implantable Device
Figure 38. World Subcutaneous Drug Delivery Equipment Production Market Share by Type (2021-2032)
Figure 39. World Subcutaneous Drug Delivery Equipment Production Value Market Share by Type (2021-2032)
Figure 40. World Subcutaneous Drug Delivery Equipment Average Price by Type (2021-2032) & (USD/Unit)
Figure 41. World Subcutaneous Drug Delivery Equipment Production Value by Delivery Mechanism, (USD Million), 2021 & 2025 & 2032
Figure 42. World Subcutaneous Drug Delivery Equipment Production Value Market Share by Delivery Mechanism in 2025
Figure 43. Manual Injection Device
Figure 44. Spring Driven Device
Figure 45. Motor Driven Device
Figure 46. Gas-Powered Device
Figure 47. World Subcutaneous Drug Delivery Equipment Production Market Share by Delivery Mechanism (2021-2032)
Figure 48. World Subcutaneous Drug Delivery Equipment Production Value Market Share by Delivery Mechanism (2021-2032)
Figure 49. World Subcutaneous Drug Delivery Equipment Average Price by Delivery Mechanism (2021-2032) & (USD/Unit)
Figure 50. World Subcutaneous Drug Delivery Equipment Production Value by Drug Type, (USD Million), 2021 & 2025 & 2032
Figure 51. World Subcutaneous Drug Delivery Equipment Production Value Market Share by Drug Type in 2025
Figure 52. Small Molecule Device
Figure 53. Peptide and Protein Device
Figure 54. Nucleic Acid Device
Figure 55. World Subcutaneous Drug Delivery Equipment Production Market Share by Drug Type (2021-2032)
Figure 56. World Subcutaneous Drug Delivery Equipment Production Value Market Share by Drug Type (2021-2032)
Figure 57. World Subcutaneous Drug Delivery Equipment Average Price by Drug Type (2021-2032) & (USD/Unit)
Figure 58. World Subcutaneous Drug Delivery Equipment Production Value by Reusability, (USD Million), 2021 & 2025 & 2032
Figure 59. World Subcutaneous Drug Delivery Equipment Production Value Market Share by Reusability in 2025
Figure 60. Disposable Device
Figure 61. Reusable Device
Figure 62. World Subcutaneous Drug Delivery Equipment Production Market Share by Reusability (2021-2032)
Figure 63. World Subcutaneous Drug Delivery Equipment Production Value Market Share by Reusability (2021-2032)
Figure 64. World Subcutaneous Drug Delivery Equipment Average Price by Reusability (2021-2032) & (USD/Unit)
Figure 65. World Subcutaneous Drug Delivery Equipment Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 66. World Subcutaneous Drug Delivery Equipment Production Value Market Share by Application in 2025
Figure 67. Disease Treatment
Figure 68. Vaccination
Figure 69. Aesthetics and Cosmetics
Figure 70. World Subcutaneous Drug Delivery Equipment Production Market Share by Application (2021-2032)
Figure 71. World Subcutaneous Drug Delivery Equipment Production Value Market Share by Application (2021-2032)
Figure 72. World Subcutaneous Drug Delivery Equipment Average Price by Application (2021-2032) & (USD/Unit)
Figure 73. Subcutaneous Drug Delivery Equipment Industry Chain
Figure 74. Subcutaneous Drug Delivery Equipment Procurement Model
Figure 75. Subcutaneous Drug Delivery Equipment Sales Model
Figure 76. Subcutaneous Drug Delivery Equipment Sales Channels, Direct Sales, and Distribution
Figure 77. Methodology
Figure 78. Research Process and Data Source
